Target intelligence / Profile preview

Mutans streptococci (MS) (MS)

Target
MS
Molecular classification
Other
01

Overview

Mutans streptococci (MS) are a group of Gram-positive, facultatively anaerobic bacteria, most notably including Streptococcus mutans and Streptococcus sobrinus, which are the primary causative agents of dental caries (StatPearls, 2023). These organisms are characterized by their ability to adhere to tooth surfaces via the synthesis of extracellular polysaccharides and form resilient biofilms known as dental plaque (NIH, 2022). Their pathogenicity is driven by acidogenesis—the fermentation of dietary sugars into organic acids—and aciduricity, which allows them to survive and continue acid production in low-pH environments, leading to enamel demineralization (PubMed, 2021). While primarily associated with oral disease, MS can enter the systemic circulation and are a recognized cause of subacute infective endocarditis (Wikipedia, 2024). Pharmacological interventions include the use of antiseptics like chlorhexidine to disrupt bacterial membranes, fluoride to inhibit metabolic enzymes and promote remineralization, and xylitol to interfere with sugar transport (Journal of Oral Microbiology, 2020). Current research focuses on developing targeted antimicrobials and vaccines to specifically reduce MS populations while preserving the healthy oral microbiome (Nature Reviews Microbiology, 2021).

Other names
Streptococcus mutans groupCariogenic streptococciMS group
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, disruption of cytoplasmic membranes, inhibition of glycolytic enzymes (e.g., enolase), and competitive inhibition of carbohydrate transport and metabolism.

03

Biological functions

Biofilm formationAcidogenesisAciduricitySucrose metabolismAdhesionOther
04

Disease associations

InfectionCardiovascular diseaseOther
05

Safety considerations

Antimicrobial resistanceOral dysbiosisFluorosis (with excessive fluoride exposure)Hypersensitivity reactions to antibiotics
06

Interacting drugs

Chlorhexidine

7 more in the full profile.

07

Biomarkers

Salivary Mutans streptococci countGlucosyltransferase activityPlaque pH levelsStreptococcus mutans DNA concentration

Beyond the preview

Go deeper on Mutans streptococci (MS) (MS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mutans streptococci (MS) (MS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call